the market?
Questcor Pharmaceuticals
NASDAQ: QCOR
47.46
1.53
(3.33%)
| Today's Open | $46.17 |
|---|---|
| Previous Close | $45.93 |
| Daily Range | $46.03 - $47.57 |
| 52-Week Range | $17.25 - $58.91 |
| Market Cap | $2.8B |
| P/E Ratio | 14.31 |
| Dividend (Yield) | $1.00 (2.2%) |
| Ex-Dividend Date Dividend Pay Date |
07/18/13 07/30/13 |
| Volume | 1,384,535 |
| Average Daily Volume | 2,328,926 |
| Current FY EPS | $4.06 |
How do you think QCOR
will perform against the market?
Top QCOR Bull/Bear Pitches
tenmiles (< 20)
Submitted
November 13, 2007
technical short after pop on MS drug sales growth - current price unsustainable
News & Commentary
5 of Last Week's Biggest Winners
These five stocks posted double-digit percentage gains last week.3 Humongous Health-Care Stocks This Week
These stocks skyrocketed this week. But will gravity soon kick in?Questcor Pop: Acquisition Trumps Competition
Questcor buys out potential competition from Novartis Synacthen and shares surge.Here's What This $4 Billion Winning Hedge Fund Company Has Bought and Sold
It can pay off to keep and eye on the big guys.Why Questcor Pharmaceuticals Shares Exploded Higher
Questcor shows the world that if you can't beat a prospective drug, you buy it!Questcor Buys Potential Rival Drug
Questcor gains rights to potential rival Synacthen. What it means for this volatile stock.Sector
Healthcare
Industry
Drugs
Questcor Pharmaceuticals (QCOR) Description
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system. Website: http://www.questcor.com/
